1-3 of 3
Michael J. Uppenkamp, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Pretransplant NPM1 -MRD Levels Predict Outcome after Allogeneic Stem Cell Transplantation in Adult Patients with Acute Myeloid Leukemia

Sabine Kayser, MD, Axel Benner, Christian Thiede, MD, Uwe Martens, MD, Josef Huber, Peter Stadtherr, Johannes W.G. Janssen, PhD, Christoph Röllig, MD, Michael J. Uppenkamp, MD, Tilmann Bochtler, MD, Ute Hegenbart, MD, Gerhard Ehninger, MD, Anthony D. Ho, MD, Peter Dreger, MD, Alwin Kraemer, MD
Journal: Blood
Blood (2015) 126 (23): 2008.
https://doi.org/10.1182/blood.V126.23.2008.2008
Published: 2015
Journal Articles

Phase I/II Study for the Effectivity of Rituximab, Gemcitabin and Oxaliplatin in Relapsed Indolent Lymphoma – An Interim Report.

Martin Hoffmann, Martin H. Dreyling, H.-P. Böck, Ulrich Dührsen, MD, PhD, Joachim Kaesberger, Stephan Kremers, Walter Lindemann, Luisa Mantovani, Michael J. Uppenkamp, MD, Michael Unterhalt, Wolfgang Hiddemann
Journal: Blood
Blood (2009) 114 (22): 3700.
https://doi.org/10.1182/blood.V114.22.3700.3700
Published: 2009
Journal Articles

Renal Safety of Ibandronate in the Treatment of Myeloma Patients.

Raoul Bergner, Jochen Breuer, Michael J. Uppenkamp, MD, Andreas Sandermann, Martin Hoffmann
Journal: Blood
Blood (2009) 114 (22): 4943.
https://doi.org/10.1182/blood.V114.22.4943.4943
Published: 2009